- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/52 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 263/52
Total number of patents in this class: 160
10-year publication summary
|
9
|
8
|
12
|
13
|
9
|
10
|
7
|
9
|
8
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2946 |
6 |
| LG Chem, Ltd. | 17662 |
5 |
| Janssen Pharmaceutica N.V. | 3610 |
5 |
| President and Fellows of Harvard College | 5914 |
5 |
| Enanta Pharmaceuticals, Inc. | 427 |
5 |
| Neumedics | 6 |
4 |
| Merck Sharp & Dohme LLC | 3750 |
4 |
| Advancion Corporation | 106 |
4 |
| Bayer Cropscience AG | 2135 |
3 |
| Commissariat à l'énergie atomique et aux energies alternatives | 10702 |
3 |
| Case Western Reserve University | 1774 |
3 |
| Georgetown University | 604 |
3 |
| Raqualia Pharma Inc. | 120 |
3 |
| Rohm and Haas Electronic Materials Korea Ltd. | 329 |
3 |
| Schering Corporation | 502 |
3 |
| Shaanxi Lighte Optoelectronics Material Co., Ltd. | 228 |
3 |
| Chromatwist Limited | 8 |
3 |
| Genentech, Inc. | 3880 |
2 |
| AstraZeneca AB | 2971 |
2 |
| Georgia Tech Research Corporation | 2627 |
2 |
| Other owners | 89 |